Page last updated: 2024-08-26

norcantharidin and Lymph Node Metastasis

norcantharidin has been researched along with Lymph Node Metastasis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, YZ; Jing, W; Li, XP; Liu, ZY; Sun, JJ; Sun, W; Zhang, JT; Zhu, W	1

Other Studies

1 other study(ies) available for norcantharidin and Lymph Node Metastasis

Article	Year
A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo. BMC cancer, 2015, Jul-19, Volume: 15 Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; In Vitro Techniques; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Nude; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays	2015

Article

Year

A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A,-C,-D/VEGFR-2,-3 "multi-points priming" mechanisms in vitro and in vivo.

BMC cancer, 2015, Jul-19, Volume: 15

Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Endothelial Cells; Gene Expression Regulation, Neoplastic; HT29 Cells; Humans; In Vitro Techniques; Lymphangiogenesis; Lymphatic Metastasis; Mice; Mice, Nude; Receptors, Vascular Endothelial Growth Factor; Vascular Endothelial Growth Factors; Xenograft Model Antitumor Assays

2015